U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:03:32 UTC 2021
Edited
by admin
on Sat Jun 26 18:03:32 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
2372V1TKXK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LANADELUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
LANADELUMAB [INN]
Common Name English
LANADELUMAB [USAN]
Common Name English
LANADELUMAB [PURPLE BOOK, CDER]
Common Name English
LANADELUMAB-FLYO
Official Name English
TAK-743
Common Name English
DX-2930
Code English
LANADELUMAB [WHO-DD]
Common Name English
LANADELUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PLASMA KALLIKREIN) (HUMAN MONOCLONAL DX-2930 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL DX-2930 LIGHT CHAIN, DIMER
Common Name English
LANADELUMAB (SHP643)
Common Name English
SHP-643
Code English
TAKHZYRO
Brand Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/15/1551
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
WHO-ATC B06AC05
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
FDA ORPHAN DRUG 397213
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
Code System Code Type Description
RXCUI
2055641
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
DRUG BANK
DB14597
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
CLINICAL_TRIALS.GOV
NCT04070326
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
LACTMED
Lanadelumab
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
NCI_THESAURUS
C166535
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
ChEMBL
CHEMBL3545189
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
MERCK INDEX
M12083
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
DRUG CENTRAL
5309
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
FDA UNII
2372V1TKXK
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
RXCUI
2055640
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
ALTERNATIVE
CAS
1426055-14-2
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
WIKIPEDIA
Lanadelumab
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
INN
10265
Created by admin on Sat Jun 26 18:03:33 UTC 2021 , Edited by admin on Sat Jun 26 18:03:33 UTC 2021
PRIMARY
From To
1_22 1_96
1_149 1_205
1_225 3_213
1_231 2_231
1_234 2_234
1_266 1_326
1_372 1_430
2_22 2_96
2_149 2_205
2_225 4_213
2_266 2_326
2_372 2_430
3_23 3_88
3_133 3_193
4_23 4_88
4_133 4_193
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_302
N 2_302
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL